Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 71872-7153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 71872-7153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (7153)

Pdp (7153)
This is a description of Dexamethasone Sodium Phosphate Injection, a medication available in a single-dose vial containing 4mg/mL, which can be administered intravenously, intramuscularly, intra-articularly, subcutaneously, or intradermally for soft tissue or intralesional use. The vial contains active ingredients Dexarethasone Sodium Phosphate and preservatives Methyparaben and Propylparaben, and inactive ingredients Edetate Disodium, Sodium Cirate, and Citc Acid and/or Sodium Hydroxd. The pH is adjusted to a range of 7.0 to 8.5 using Citc Acid and/or Sodium Hydroxd and Water for Injection. The dosage should follow the package insert, and it should be stored at 20°C to 25°C and protected from light and heat. The manufacturer is Mylan hettutons LLG Rockdorl, 1L 81109 U S A with Manufacturer NOC 67457-0423-12, and it has USP convolved on the tamper-proof packaging. There is also a reference to wwwmedcalpurchasingsolutons.cor, a medical purchasing solution website.*
FDA Label Image

Structure (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.